Clinical trial
Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether +…
NCT00229775 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00229775 |
|---|---|
| Title | Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines |
| Official title | Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Department of Health, Philippines |
| Status | Completed |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | artemether/lumafantrine vs chloroquine/sulfadoxine-pyrimethamine |
| Enrollment | 560 |
| Start date | Jul 1, 2003 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Sep 30, 2005 |
| Last update posted | Sep 11, 2012 |
| Countries | Philippines |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: